Sonoma pharmaceuticals introduces next generation solution for pulse lavage irrigation in the european union

Boulder, co / accesswire / june 8, 2023 / sonoma pharmaceuticals, inc. (nasdaq:snoa), a global healthcare leader developing and producing patented microcyn® technology based stabilized hypochlorous acid (hocl) products for a wide range of applications, including wound care, dermatology, and eye, oral and nasal care, today announced a new application for intraoperative pulse lavage irrigation treatment, which can replace commonly used iv bags in a variety of surgical procedures. sonoma developed this new application of its wound care technology in response to an unmet need for a non-toxic irrigation solution that can prevent infection and improve healing time.
SNOA Ratings Summary
SNOA Quant Ranking